Skip to main content
. Author manuscript; available in PMC: 2017 Feb 19.
Published in final edited form as: Nanoscale. 2017 Jan 26;9(4):1575–1579. doi: 10.1039/c6nr08496f

Fig. 4.

Fig. 4

Dual-function of TT3-Gd18 LLNs in vivo. (A) TT3-Gd18 LLNs delivery of Fluc mRNA. A significant bioluminescence signal was observed in treated groups compared with the untreated groups (n=3). (B–D) T1 weighted images of mouse legs 20 min (B), 1 h (C), and 6 h (D) after intramuscular injection of TT3-Gd18 LLNs (n=1).